共 10 条
[1]
Smith, Review of clinical experience with digoxin immune Fab (ovine), Am J Emerg Med, 9, pp. 1-6, (1991)
[2]
Smith, Review of clinical experience with digoxin immune Fab (ovine), Am J Emerg Med, 9, pp. 33-34, (1991)
[3]
Hursting, Raisys, Opheim, Et al., Determination of free digoxin concentrations in serum for monitoring Fab treatment of digoxin overdose, Clin Chem, 33, pp. 1652-1655, (1987)
[4]
Gibb, Adams, Parnham, Et al., Plasma digoxin: Assay anomalies in Fab-treated patients, Br J Pharmacol, 16, pp. 445-447, (1983)
[5]
Pieroni, Fisher, Use of cholestyramine resin in digotoxin toxicity, JAMA, 245, pp. 1939-1940, (1981)
[6]
Schaumann, Kaufmann, Neubert, Et al., Kinetics of the Fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication, Eur J Clin Pharmacol, 30, pp. 527-533, (1986)
[7]
Hursting, Raisys, Opheim, Drug specific Fab therapy in drug overdose, Arch Pathol Lab Med, 111, pp. 693-697, (1987)
[8]
Shumaik, Wu, Ping, Oleander poisoning: Treatment with digoxin-specific Fab antibody fragments, Ann Emerg Med, 17, pp. 732-735, (1988)
[9]
Clark, Selden, Curry, Digoxin-specific Fab fragments in the treatment of oleander toxicity in the canine model, Ann Emerg Med, 20, pp. 1073-1077, (1991)
[10]
Hickey, Wenger, Et al., Digoxin immune Fab therapy in the managment of digitalis intoxication: Safety and efficacy results of an observational surveillance study, J Am Coll Cardiol, 17, pp. 590-598, (1991)